AJJ Medtech (SGX:584) narrowed its attributable loss in Q3 to SG$795,000 from SG$1.0 million a year earlier, according to a Wednesday filing with the Singapore Exchange.
Shares of the company were down over 9% in Thursday trading.
Loss per share came in at SG$0.00053 compared with SG$0.00079 in the comparable period.
Revenue jumped 87% year over year to SG$483,000 from SG$259,000, mainly due to improve performance from the healthcare products and services segment.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.